Observation of inverse Compton emission from a long γ-ray burst.

Long-duration γ-ray bursts (GRBs) originate from ultra-relativistic jets launched from the collapsing cores of dying massive stars. They are characterized by an initial phase of bright and highly variable radiation in the kiloelectronvolt-to-megaelectronvolt band, which is probably produced within the jet and lasts from milliseconds to minutes, known as the prompt emission1,2. Subsequently, the interaction of the jet with the surrounding medium generates shock waves that are responsible for the afterglow emission, which lasts from days to months and occurs over a broad energy range from the radio to the gigaelectronvolt bands1-6. The afterglow emission is generally well explained as synchrotron radiation emitted by electrons accelerated by the external shock7-9. Recently, intense long-lasting emission between 0.2 and 1 teraelectronvolts was observed from GRB 190114C10,11. Here we report multi-frequency observations of GRB 190114C, and study the evolution in time of the GRB emission across 17 orders of magnitude in energy, from 5 × 10-6 to 1012 electronvolts. We find that the broadband spectral energy distribution is double-peaked, with the teraelectronvolt emission constituting a distinct spectral component with power comparable to the synchrotron component. This component is associated with the afterglow and is satisfactorily explained by inverse Compton up-scattering of synchrotron photons by high-energy electrons. We find that the conditions required to account for the observed teraelectronvolt component are typical for GRBs, supporting the possibility that inverse Compton emission is commonly produced in GRBs

Formulation, stabilisation and encapsulation of bacteriophage for phage therapy

Against a backdrop of global antibiotic resistance and increasing awareness of the importance of the human microbiota, there has been resurgent interest in the potential use of bacteriophages for therapeutic purposes, known as phage therapy. A number of phage therapy phase I and II clinical trials have concluded, and shown phages don’t present significant adverse safety concerns. These clinical trials used simple phage suspensions without any formulation and phage stability was of secondary concern. Phages have a limited stability in solution, and undergo a significant drop in phage titre during processing and storage which is unacceptable if phages are to become regulated pharmaceuticals, where stable dosage and well defined pharmacokinetics and pharmacodynamics are de rigueur. Animal studies have shown that the efficacy of phage therapy outcomes depend on the phage concentration (i.e. the dose) delivered at the site of infection, and their ability to target and kill bacteria, arresting bacterial growth and clearing the infection. In addition, in vitro and animal studies have shown the importance of using phage cocktails rather than single phage preparations to achieve better therapy outcomes. The in vivo reduction of phage concentration due to interactions with host antibodies or other clearance mechanisms may necessitate repeated dosing of phages, or sustained release approaches. Modelling of phage-bacterium population dynamics reinforces these points. Surprisingly little attention has been devoted to the effect of formulation on phage therapy outcomes, given the need for phage cocktails, where each phage within a cocktail may require significantly different formulation to retain a high enough infective dose. This review firstly looks at the clinical needs and challenges (informed through a review of key animal studies evaluating phage therapy) associated with treatment of acute and chronic infections and the drivers for phage encapsulation. An important driver for formulation and encapsulation is shelf life and storage of phage to ensure reproducible dosages. Other drivers include formulation of phage for encapsulation in micro- and nanoparticles for effective delivery, encapsulation in stimuli responsive systems for triggered controlled or sustained release at the targeted site of infection. Encapsulation of phage (e.g. in liposomes) may also be used to increase the circulation time of phage for treating systemic infections, for prophylactic treatment or to treat intracellular infections. We then proceed to document approaches used in the published literature on the formulation and stabilisation of phage for storage and encapsulation of bacteriophage in micro- and nanostructured materials using freeze drying (lyophilization), spray drying, in emulsions e.g. ointments, polymeric microparticles, nanoparticles and liposomes. As phage therapy moves forward towards Phase III clinical trials, the review concludes by looking at promising new approaches for micro- and nanoencapsulation of phages and how these may address gaps in the field

Oxo chemistry in supercritical carbon dioxide

We report an investigation of the cobalt carbonyl-catalyzed oxo process in supercritical CO{sub 2} using in situ high pressure NMR spectroscopy. The use of supercritical CO{sub 2} as the solvent medium eliminates gas-liquid mixing problems. The effect of supercritical CO{sub 2} on the oxo reaction was determined by comparing the linear to branched aldehyde yield and rate and other equilibrium processes involved in the catalytic cycle with measured values in conventional liquid solvents

Applications of toroids in high-pressure NMR spectroscopy

Toroid detectors have distinct NMR sensitivity and imaging advantages. The magnetic field lines are nearly completely contained within the active volume element of a toroid. This results in high NMR signal sensitivity. In addition, the toroid detector may be placed next to the metallic walls of a containment vessel with minimal signal loss due to magnetic coupling with the metal container. Thus, the toroid detector is ideal for static high pressure or continuous flow monitoring systems. Toroid NMR detectors have been used to follow the hydroformylation of olefins in supercritical fluids under industrial process conditions. Supercritical fluids are potentially ideal media for conducting catalytic reactions that involve gaseous reactants, including H{sub 2}, CO, and CO{sub 2}. The presence of a single homogeneous reaction phase eliminates the gas-liquid mixing problem of alternative two-phase systems, which can limit process rates and adversely affect hydroformylation product selectivities. A second advantage of toroid NMR detectors is that they exhibit a well-defined gradient in the rf field. This magnetic field gradient can be used for NMR imaging applications. Distance resolutions of 20 {mu} have been obtained

Job creation due to nuclear power resurgence in the United States

The recent revival of global interest in the next generation of nuclear power reactors is causing a re-examination of the role of nuclear power in the United States. This renewed interest has led to questions regarding the capability and capacity of current US industries to support a renewal of nuclear power plant deployment. Key among the many questions currently being asked is what potential exists for the creation of new jobs as a result of developing and operating these new plants? Idaho National Laboratory and Bechtel Power Corporation collaborated to perform a Department of Energy-sponsored study that evaluated the potential for job creation in the United States should these new next generation nuclear power plants be built. The study focused primarily on providing an initial estimate of the numbers of new manufacturing jobs that could be created, including those that could be repatriated from overseas, resulting from the construction of these new reactors. In addition to the growth in the manufacturing sector, the study attempted to estimate the potential increase in construction trades necessary to accomplish the new construction.US job creation Commercial nuclear industry Future energy demand